Precision allosteric therapeutics
inspired by the body’s natural regulators
Leveraging the body’s natural regulators to accelerate the discovery of precision allosteric small molecule therapeutics
By integrating our proprietary screening technology with our powerful AI-enabled drug discovery platform, we are able to efficiently identify novel, biologically relevant allosteric sites for protein or RNA targets, and rapidly advance structural insights into small molecule therapeutics design.
Transformative Potential
Precision allosteric small molecules offer better treatment options for patients across a broad range of diseases. We are internally focused on precision oncology and rare diseases with plans to leverage partnerships for other therapeutic areas.
Together we are on a mission
to discover precision allosteric therapeutics that can transform
the treatment of serious diseases.